Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
LY2
HR+
Luminal
TCS PIM-1 1
Pim kinase
PIM
10816.148
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.7402
CAMA-1
HR+
Luminal
Cetuximab
EGFR
ErbB
7805.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0217
-0.4906
1.1451
MDA-MB-157
TNBC
Basal B
Sirolimus
MTOR
MTOR
7495.069
uM
inf
inf
1.0500 1.0500 0.0000 0.0388
0.0179
0.5089
HCC1937
TNBC
Basal A
Nilotinib
ABL
nRTK
11849.145
uM
inf
inf
1.0500 1.0500 0.0000 0.0324
0.0000
1.5253
MDA-MB-415
HR+
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7510.094
uM
inf
inf
1.0500 1.0500 0.0000 -0.0419
-8.1247
0.8152
HCC2185
TNBC
Luminal
Nilotinib
ABL
nRTK
12192.145
uM
inf
inf
1.0500 1.0500 0.0000 -0.0217
-0.1880
0.4175
MX1
Unknown
Unknown
Nilotinib
ABL
nRTK
10874.145
uM
inf
inf
1.0500 1.0500 0.0000 -0.0057
-0.0198
0.8505
MCF 10A
NM
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7483.095
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
2.6732
MDA-MB-134-VI
HR+
Luminal
Epirubicin
TOP2
TOP
7877.017
uM
inf
inf
1.0500 1.0500 0.0000 0.1618
0.3038
0.6955
MDA-MB-361
HER2amp
Luminal
Sulindac sulfide
COX1/2
COX
10643.136
uM
inf
inf
1.0500 1.0500 0.0000 -0.0432
-6.6439
0.5141
HCC70
TNBC
Basal A
Nilotinib
ABL
nRTK
10873.145
uM
inf
inf
1.0500 1.0500 0.0000 0.0001
-0.0012
1.2454
MDA-MB-415
HR+
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
9664.049
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.7193
LY2
HR+
Luminal
FR180204
ERK1/2
MAPK
10816.149
uM
inf
inf
1.0500 1.0500 0.0000 -0.0238
-0.1642
0.4545
MDA-MB-361
HER2amp
Luminal
SB-3CT
MMP2/9
MMP
12379.168
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.4672
HCC1806
TNBC
Basal A
Erlotinib
EGFR
ErbB
7450.091
uM
inf
inf
1.0500 1.0500 0.0000 -0.0008
0.1356
1.0419
MCF 10A
NM
Basal B
Nilotinib
ABL
nRTK
11056.145
uM
inf
inf
1.0500 1.0500 0.0000 -0.0366
-2.6666
2.8383
MDA-MB-436
TNBC
Basal B
PD184352
MEK
MAPK
7898.029
uM
inf
inf
1.0500 1.0500 0.0000 0.0820
0.0614
0.7130
BT-20
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
5902.095
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
1.0245
BT-20
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
10385.095
uM
inf
inf
1.0500 1.0500 0.0000 0.0010
0.0617
0.7986
SUM1315MO2
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7528.071
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.5828
SUM159PT
TNBC
Basal B
PS-1145
IKK
NFKB
7531.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0370
-7.5867
3.4461
SUM159PT
TNBC
Basal B
Ro 32-0432
PKC
PKC
10520.142
uM
inf
inf
1.0500 1.0500 0.0000 -0.0236
-0.3274
3.1766
MDA-MB-231
TNBC
Basal B
PS-1145
IKK
NFKB
7504.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0441
-20.3886
1.6220
MDA-MB-361
HER2amp
Luminal
JNK-IN-5A
JNK
JNK
10999.144
uM
inf
inf
1.0500 1.0500 0.0000 0.1189
0.2272
0.6880
HCC38
TNBC
Basal B
Nilotinib
ABL
nRTK
11850.145
uM
inf
inf
1.0500 1.0500 0.0000 0.0017
-0.0001
2.1492